Skip to main content

Search This Blog

Prostate Cancer

Posts

Melatonin for cancer patients: Is it safe?

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 26, 2026

Invalid Access Key! Invalid Access Key!

12 Rare Cancers: Symptoms, Treatment, and Outlook

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 26, 2026

Invalid Access Key! Invalid Access Key!

10 things to know about neuroendocrine tumors

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 26, 2026

Invalid Access Key! Invalid Access Key!

12 Rare Cancers: Symptoms, Treatment, and Outlook

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 25, 2026

Invalid Access Key! Invalid Access Key!

10 things to know about neuroendocrine tumors

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 25, 2026

Invalid Access Key! Invalid Access Key!

Ranked the Best Cancer Center in the Northeast and First in the Nation for Urology Care by U.S. News & World Report | Memorial Sloan Kettering Cancer Center

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 17, 2026

Invalid Access Key! Invalid Access Key!

Can watery eyes be a sign of cancer?

Get link
Facebook
X
Pinterest
Email
Other Apps

- October 17, 2026

Invalid Access Key! Invalid Access Key!

Powered by Blogger

Theme images by billnoll

Popular Posts

Switching Immune Cells From “Protect” to “Attack” Mode To Treat Prostate Cancer - Technology Networks

- July 03, 2020

Drugs that can ‘reprogramme’ immune cells from protecting cancer to attacking it could be an effective new treatment for some men with advanced prostate cancer, a new study shows. Researchers found that immune cells called macrophages, already drawn into prostate cancer tumours to help promote growth, can be targeted and rewired to attack the disease. In studies of cancer cells and mice with prostate cancer a so-called CXCR2 inhibitor, which blocks a protein receptor on macrophages, inhibited tumour growth by switching them from helping the tumour to triggering anti-tumour immune responses instead. The drug, called AZD5069, is now being studied in a clinical trial led by researchers at The Institute of Cancer Research and our partner hospital The Royal Marsden NHS Foundation Trust, to test its effectiveness in men with advanced prostate cancer. The new research, published in the journal published in the journal Cell Reports , was carried out by a Eur...

Prostate cancer: Investigating the impact of diet - Medical News Today

- October 23, 2019

A recent review searches for links between dietary choices and prostate cancer. The authors conclude that there may be an association between plant based diets and a decreased risk of prostate cancer, as well as a link between dairy intake and increased risk. Share on Pinterest The relationship between diet and disease will not give up its secrets easily. According to the National Cancer Institute, there will be an estimated 174,650 new cases of prostate cancer in the United States this year. In the U.S., about 11.6% of men will receive a diagnosis of prostate cancer at some point during their lifetime. As with other types of cancer , scientists are still uncovering the full range of risk factors for prostate cancer. Some scientists have turned to nutrition , but — for various reasons — measuring the effect of the diet on disease is notoriously difficult. As one example, food intake can fluctuate wildly from day to day, month to month, and year to year. Also, certain dietary ...

Prostate cancer: Noninvasive urine test moves a step closer - Medical News Today

- April 14, 2020

Researchers have identified a unique molecular signature of prostate cancer in urine. This may pave the way for an accurate, noninvasive test for the condition. Share on Pinterest Recent research could help pave the way for a new urine test for prostate cancer. The scientists — from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD — used RNA and other molecules in urine to differentiate between males with prostate cancer and those with nonmalignant prostate conditions or healthy prostates. Prostate cancer is the second most common cancer among males in the United States, after skin cancer. Around 1 in 9 males will receive a diagnosis of this condition in their lifetime. In the U.S. alone, almost 192,000 males will receive a diagnosis in 2020, and over 33,000 will die from the condition. Prostate cancer is highly treatable, especially if a doctor diagnoses it early. However, there are often no symptoms in the early stages, and existing screening tes...

Tips to be fit: Should you get prostate cancer screening? - The Philadelphia Tribune

- February 24, 2020

Recent news article have suggested that healthy men don’t need to have routine prostate screenings. At first you might say, “Well I’m healthy. Maybe I’ll skip it this time.” Should you? A few years ago the United States Preventive Services Task Force said in a report that routine “prostate-specific antigen” (PSA) screenings does not save lives. Their conclusion was based on five major clinical studies. The two largest studies conducted in the U.S. and Europe found that the death rates of men who got prostate screenings were virtually the same as those who didn’t. Is this reason enough not to have a routine prostate screenings? What most people and even some doctors don’t understand is that a PSA screening is not a specific test for cancer. It’s a test that can detect abnormalities. It doesn’t identify a particular problem. One doctor put it this way “A PSA screening is like an engine warning light. When it flashes, you can’t tell if a particular spark plug is bad. It tells you on...

Man With Prostate Cancer Placing His Beliefs on Power of Olive Oil - The Pappas Post

- March 26, 2019

Genotype linked to shorter survival in metastatic prostate cancer - Urology Times

- March 02, 2020

Inheriting the adrenal-permissive HSD3B1(1245C) genotype is associated with worse outcomes in low-volume metastatic prostate cancer and might someday help identify patients who could benefit from escalated therapy, according to a recent study. In essence, some patients are genetically predisposed to having their prostate cancers make their own potent androgens, such as testosterone or dihydrotestosterone (DHT), from non-testicular sources, according to study author Nima Sharifi, MD, of Cleveland Clinic Genitourinary Malignancies Research Center, Cleveland. “This comes from germline inheritance of an effectively ‘fast’ enzyme by the gene HSD3B1 that allows for prostate cancer to make these androgens. What this means clinically is that men with low-volume metastatic prostate cancer who inherit this fast form of HSD3B1 treated with medical or surgical castration progress more quickly and have shorter survival compared with men who do not inherit this fast enzyme,” Dr. Sharifi said. Re...

Finasteride Effective in Preventing Prostate Cancer - Targeted Oncology

- February 16, 2019

Ian Thompson, Jr, MD According to the final analysis of the Prostate Cancer Prevention Trial (PCPT), finasteride (Proscar), an agent commonly used to treat lower urinary tract problems and baldness in men, was safe and effective in reducing the risk of prostate cancer. The findings were recently published published in the New England Journal of Medicine . 1 “Finasteride is safe, inexpensive, and effective as a preventive strategy for prostate cancer,” principal investigator Ian Thompson, Jr, MD, chair of SWOG's Genitourinary Cancer committee, and president of CHRISTUS Santa Rosa Hospital Medical Center, said in a press release. “Doctors should share these results with men who get regular prostate-specific antigen (PSA) tests that screen for the presence of prostate cancer. The drug will have its greatest effect in this group of men.” The initial SWOG Cancer Research Network PCPT trial, which was funded by the National Cancer Institute, first opened for enrollmen...

Cancer Patients Reveal The Symptom That Made Them Think Something Might Be Wrong

- September 21, 2026

Invalid Access Key! Invalid Access Key!

Minimally invasive treatment option for enlarged prostate - PAHomePage.com

- February 28, 2019

After Beating Cancer Twice, Larry King, 87, Has Died– Legendary Talk Show Host Had Incredible Staying Power - SurvivorNet

- August 18, 2021

Larry King, Hospitalized With COVID-19, Is a Warrior Larry King Live talk show host Larry King, 87, is currently in the hospital fighting COVID-19; he reportedly left the ICU on Sunday. King survived lung cancer in 2017 and prostate cancer in 1999; he has also suffered a stroke and heart disease in the past. For people battling cancer during the COVID-19 pandemic, it's especially important to exercise safety precautions, due to some cancer treatments leading to an immunocompromised state. Legendary TV host and broadcast journalist, Larry King, 87, has spoken of his "indomitable spirit" which allowed him to overcome multiple health issues, including lung cancer in 2017; now, King has passed away from cancer after a battle with COVID. He had previously been treated at Cedars Sinai Medical Center in Los Angeles. And due to safety protocols, it's being reported by CNN that his three sons are not able to visit him in the hospital. Related: A Message on World Lung Cancer D...

Archive

October 202628
September 202634
August 202650
July 202656
June 202644
May 202631
April 202658
March 2026111
February 202677
January 202687

Show more Show less

Labels

"cancer prostata" - Google News
"metastatic prostate cancer" - Google News
"prostate cancer causes" - Google News
"prostate cancer survival rate" - Google News
"prostate cancer treatment options" - Google News
"prostate cancer treatment" - Google News
"prostate cancer" - Google News
"prostatectomy" - Google News
"symptoms of prostate cancer in men" - Google News
cancer+prostata - Google News

Google News
IFTTT
metastatic prostate cancer
metastatic+prostate+cancer - Google News
prostate cancer
prostate cancer causes
prostate cancer survival rate
prostate cancer treatment
prostate cancer treatment options
prostate+cancer - Google News
prostate+cancer+causes - Google News
prostate+cancer+survival+rate - Google News
prostate+cancer+treatment - Google News
prostate+cancer+treatment+options - Google News
prostatectomy
prostatectomy - Google News
symptoms of prostate cancer in men
symptoms+of+prostate+cancer+in+men - Google News

Show more Show less